Recombinant Human TMPRSS13 protein
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human TMPRSS13 protein is a Human Fragment protein, in the 182 to 279 aa range, expressed in Wheat germ, suitable for ELISA, WB.
View Alternative Names
MSP, TMPRSS11, TMPRSS13, Transmembrane protease serine 13, Membrane-type mosaic serine protease, Mosaic serine protease
- SDS-PAGE
Unknown
SDS-PAGE - Recombinant Human TMPRSS13 protein (AB164478)
ab164478 on a 12.5% SDS-PAGE stained with Coomassie Blue.
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Specifications
Form
Liquid
General info
Function
Serine protease (PubMed : 20977675, PubMed : 28710277, PubMed : 34562451). Cleaves the proform of PRSS8/prostasin to form the active protein (PubMed : 34562451). Cleaves the proform of HGF to form the active protein which promotes MAPK signaling (PubMed : 20977675). Promotes the formation of the stratum corneum and subsequently the epidermal barrier in embryos (By similarity).
Sequence similarities
Belongs to the peptidase S1 family.
Post-translational modifications
The inactive zymogen is post-translationally modified and then trafficked to the cell surface, whereby it undergoes autocatalytic cleavage resulting in an activated form that is released extracellularly.. Phosphorylation is required for localization at the cell surface (PubMed:28710277, PubMed:34562451). Phosphorylation increases following inhibition of protease activity by SPINT2/HAI-2 (PubMed:35796294).. N-glycosylation of Asn-405 and Asn-445 is required for exit from the endoplasmic reticulum and trafficking to the cell surface (PubMed:28710277, PubMed:34562451). Also required for autocleavage of the zymogen, activation and secretion of the mature protein (PubMed:34562451).
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com